[Diabetic nephropathy--manage now!].
Ritz
E
E
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003928:Diabetic Nephropathies / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D005544:Forecasting; D006293:Health Promotion / Q000639:trends*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D008403:Mass Screening / Q000639:trends; D012307:Risk Factors
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors